1 / 31

Hematological Alterations

Hematological Alterations . NUR 264 Pediatrics Angela Jackson, RN, MSN. Hematological Alterations: Developmental Differences. During fetal development, blood cells are produced in the liver and the spleen In the newborn, blood cells are produced from stem cells in the bone marrow

vwebster
Télécharger la présentation

Hematological Alterations

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Hematological Alterations NUR 264 Pediatrics Angela Jackson, RN, MSN

  2. Hematological Alterations: Developmental Differences • During fetal development, blood cells are produced in the liver and the spleen • In the newborn, blood cells are produced from stem cells in the bone marrow • Full- term newborns are able to store iron in the bone marrow and liver tissue for up to 20 weeks • Premature newborns may use up their iron stores within 6-12 weeks

  3. Iron Deficiency Anemia • Most common hematologic disorder of infancy and childhood • The body does not have enough iron to synthesize the hemoglobin necessary to carry oxygen to the tissues • Affects 9% of toddlers 1-2 years of age • Affects 4% of children 3-4 years of age • Incidence rates are higher in low income families

  4. Iron Deficiency Anemia: Pathophysiology • Dietary iron is absorbed in the small intestine and is either passed into the bloodstream or is stored as ferritin • Iron in the blood stream binds to transferrin and is delivered to the bone marrow, where it is combined with other components to form hemoglobin • Iron may also be recycled from RBC’s that have been removed from the bloodstream and catabolized • When a child does not ingest enough iron, hemoglobin synthesis is impaired • When a child experiences blood loss, there are fewer RBC’s to be catabolized and the iron in these cells cannot be recycled

  5. Iron Deficiency Anemia:Clinical Manifestations • Mild anemia: • Generally asymptomatic • May experience symptoms of moderate anemia during exertion • Moderate anemia: • Shortness of breath • Rapid, pounding heart beat • Dizziness, fainting, lethargy, irritability • Severe anemia: • Cardiac murmurs • Pale skin, mucous membranes, lips, nail beds and conjunctiva • Thinning and early graying of the hair • Abdominal pain, nausea, vomiting, anorexia, low-grade fever • Decreased physical growth, developmental delay

  6. Iron Deficiency Anemia:Diagnosis • History and physical exam • Laboratory studies: • Decreased hemoglobin, hematocrit, MCV(RBC volume), MCH(weight of Hb within a RBC), MCHC(concentration of Hb in a RBC), serum iron, serum ferritin • Microcytic, hypochromic RBC’s • Increased Total iron binding capacity • Normal retic count • Normal hemoglobin electrophoresis

  7. Iron Deficiency Anemia:Treatment • Infants: Breast milk or iron-fortified formula until 4-6months, then add iron-fortified cereal • School-age children and adolescents: restrict amount of milk, encourage iron-rich foods and foods high in vitamin C • Iron supplements: • Infants and preschoolers: 3mg/kg/day • School-age children: 60mg/day • Adolescents: 120mg/day

  8. Iron-Deficiency Anemia:Nursing Considerations • Family Teaching • Nutrition: foods high and iron, and foods high in Vitamin C • Medication dosages and administration • Side effects of medication • Follow-up

  9. Sickle Cell Anemia • Autosomal recessive disorder • Occurs in approximately 1 in every 500 African-American births and 1 in every 1000-1400 Hispanic American births • Sickle cell trait is present in 1 in 12 African-Americans

  10. Sickle Cell Anemia:Pathophysiology • One amino acid replaces another, resulting in the production of sickle hemoglobin (Hb S) • This form of hemoglobin contains a semi-solid gel that caused the RBC to stretch into a sickle shape • These cells are more stiff and less able to change shape, and are unable to pass through the microcirculation • Anemia results from increased RBC destruction, worsened by the fact that sickled cells die after only 10-20 days

  11. Sickle Cell Anemia: Clinical Manifestations • Vaso-occlusive crisis: aggregation of sickled cells within a vessel, causing obstruction. • Pain crisis • Hand-foot syndrome • Acute chest syndrome • Stroke • Priapism • Sequestration crisis: excessive pooling of blood in the liver and spleen. Decreased blood volume may result in shock. • Aplastic crisis: decrease in red blood cell production. Results in severe anemia • Pallor, fatigue, shortness of breath • Delayed growth • Delayed onset of puberty

  12. Sickle Cell Anemia:Diagnosis • Family history and clinical manifestations • Newborn Screening • Lab tests: • Increased retic count • Decreased Hgb &Hct and TIBC • Hemoglobin electrophoresis reveals predominantly Hb S • Normocytic, normochromic, sickle shaped cells • Normal MCV, MCH, MCHC • Normal serum iron and serum ferritin

  13. Sickle Cell Anemia:Treatment • Primary treatment is prevention of RBC sickling • Avoidance of fever, infection, acidosis, dehydration, constrictive clothing and exposure to cold • Immunization • Prophylactic oral penicillin until age 5 • Routine blood transfusions for children at high risk of CVA

  14. Sickle Cell Anemia:Nursing Considerations • Promote comfort • Administer pain medication routinely instead of PRN • Apply heat to painful areas • Allow child to determine amount of activity tolerated • Provide passive ROM exercises • Administer IV fluids as ordered to maintain hydration • Prevent infection • Administer antibiotics as ordered • Frequent hand washing • Proper aseptic techniques • Provide education • Maintain adequate hydration • Avoid sources of infection • Promote proper nutrition • Signs and symptoms of crisis • Administration of prophylactic medications

  15. Hemophilia • Group of bleeding disorders in which one factor in the first phase of coagulation is deficient • Most common type is hemophilia A (deficiency of factor VIII), occurs in approximately 1:5000 males • Hemophilia B (Christmas disease, deficiency of factor IX) second most common type, affects 10-15% of people with hemophilia • Least common type is hemophilia C (deficiency of factor XI) • Hemophilia A and B are x-linked recessive disorders, affecting mostly males. Hemophilia C is an autosomal recessive disorder that affects males and females equally

  16. Hemophilia:Pathophysiology • One factor of the first phase of the intrinsic pathway is deficient • The body is unable to form clots to repair damaged blood vessels • Bleeding episodes occur

  17. Hemophilia: Clinical Manifestations • Clinical manifestations vary based on severity of the disease • Mild: excessive bleeding only after severe trauma or surgery • Moderate: excessive bleeding only after trauma • Severe: excessive bleeding occurs spontaneously • Hematomas may result from injections or firm holding during the first year of life

  18. Hemophilia:Clinical Manifestations • As the child learns to walk, bruising occurs easily, and hemarthrosis may develop • Persistent bleeding from minor lacerations begin to occur by 3-4 years of age • Minor occurrences of hematuria, epistaxis as well as major events such as intracranial hemorrhage and bleeding into the neck or abdomen may also occur

  19. Hemophilia:Diagnosis • History and physical exam • Lab tests: • Prolonged PTT • Normal platelet count, standard bleeding time, and PT

  20. Hemophilia:Treatment • Hemophilia A: • Replacement of missing coagulation factor through infusion of recombinant factor VIII concentrates • May be administered three or four times/week • Desmopressin (DDAVP) is effective for spontaneous bleeding and in preventing bleed prior to dental or surgical procedures

  21. Hemophilia:Treatment • Hemophilia B: • Replacement of factor IX through plasma derived concentrates • DDAVP is not effective • Hemophilia C: Aggressive therapy is usually unnecessary because of the mild nature of the disease

  22. Hemophilia:Nursing Considerations • Prevent bleeding: • Make the environment as safe as possible for infants learning to walk • Encourage noncontact sports in the school age child • Soft-bristled toothbrushes for mouth care and electric razors for shaving • Prevent IM injections whenever possible • Wear medic alert bracelet

  23. Hemophilia: Nursing Considerations • Recognize and manage bleeding: • Make family aware of signs and symptoms of internal bleeding such as headache, slurred speech, loss of consciousness, black tarry stools, hematemesis, hematuria • Factor replacement should be instituted according to established medical protocol • Apply pressure to the bleeding area for at least 10-15 minutes • Immobilize and elevate the area above the level of the heart to decrease blood flow • Apply cold to promote vasoconstriction

  24. Hemophilia:Nursing Considerations • Prevent crippling effects of joint degeneration resulting from hemarthrosis: • Elevate and immobilize the joint • Passive range of motion after the acute phase • Physical therapy • Nutrition counseling to maintain optimal weight • May need orthopedic intervention such as casting, traction or aspiration of blood to preserve joint function

  25. Hemophilia:Nursing considerations • Family teaching: • Administration of antihemophilic factor concentrates • Methods to prevent or stop bleeding • Signs and symptoms that indicate an emergent situation and the need for immediate physician intervention • Provide support • Genetic counseling

  26. Immune Thrombocytopenic Purpura (ITP) • Acquired disease characterized by thrombocytopenia and purpura • Autoimmune disorder • Peak incidence between 2 and 4 • 75% of children recover completely in 3 months • 80-90% have regained normal platelet counts within 6 months

  27. ITP:Pathophysiology • Platelets adhere to injured vessel walls, release biochemical mediators, and form plugs, blocking minute ruptures occurring in the microcirculation • Inadequate numbers of platelets result in purpura under the skin and throughout the tissues • This occurs as the result of an autoimmune process that is triggered by a viral infection • Antiplatelet antibodies bind to the platelets, sequestering and destroying them in the spleen

  28. ITP:Clinical Manifestations • Ecchymoses, general petechial rash occurring 1-4 weeks following a viral infection • Asymmetrical bleeding, especially on legs and trunk • Gastrointestinal or urinary tract bleeding may occur • Nose bleeding may be present and difficult to control • Intracranial hemorrhage occurs in only 1% of patients

  29. ITP:Diagnosis • History and clinical presentation • Peripheral blood smear with very few, large, immature platelets • Bone marrow aspiration will be normal • Lab tests: • Decreased platelet count • Prolonged standard bleeding time • Normal PT and PTT

  30. ITP:Treatment • Self-limiting condition • Prevent injury • Control bleeding • Immunosuppressive medication if sever symptoms are present • Prednisone • Gamma globulin

  31. Questions?

More Related